{
    "startDate": "2018-01-01",
    "endDate": "2018-09-30",
    "year": "2018",
    "quarter": "Q3",
    "symbol": "BIIB",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 2386700000
            },
            {
                "label": "Marketable securities",
                "concept": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
                "unit": "usd",
                "value": 2041700000
            },
            {
                "label": "Accounts receivable, net",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 2017300000
            },
            {
                "label": "Due from anti-CD20 therapeutic programs",
                "concept": "biib:DuefromantiCD20therapeuticprograms",
                "unit": "usd",
                "value": 508400000
            },
            {
                "label": "Inventory",
                "concept": "InventoryNet",
                "unit": "usd",
                "value": 916600000
            },
            {
                "label": "Other current assets",
                "concept": "OtherAssetsCurrent",
                "unit": "usd",
                "value": 848300000
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 8719000000
            },
            {
                "label": "Marketable securities",
                "concept": "AvailableForSaleSecuritiesDebtSecuritiesNoncurrent",
                "unit": "usd",
                "value": 1244500000
            },
            {
                "label": "Property, plant and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 3538900000
            },
            {
                "label": "Intangible assets, net",
                "concept": "IntangibleAssetsNetExcludingGoodwill",
                "unit": "usd",
                "value": 3379000000
            },
            {
                "label": "Goodwill",
                "concept": "Goodwill",
                "unit": "usd",
                "value": 5440100000
            },
            {
                "label": "Deferred tax assets",
                "concept": "DeferredTaxAssetsLiabilitiesNetNoncurrent",
                "unit": "usd",
                "value": 2160900000
            },
            {
                "label": "Investments and other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 1009800000
            },
            {
                "label": "ASSETS",
                "concept": "Assets",
                "unit": "usd",
                "value": 25492200000
            },
            {
                "label": "Current portion of notes payable",
                "concept": "DebtCurrent",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Taxes payable",
                "concept": "TaxesPayableCurrent",
                "unit": "usd",
                "value": 254100000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 342300000
            },
            {
                "label": "Accrued expenses and other",
                "concept": "OtherLiabilitiesCurrent",
                "unit": "usd",
                "value": 2578500000
            },
            {
                "label": "Current liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 3174900000
            },
            {
                "label": "Notes payable",
                "concept": "LongTermDebt",
                "unit": "usd",
                "value": 5931100000
            },
            {
                "label": "Deferred tax liabilities",
                "concept": "DeferredTaxLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 1114600000
            },
            {
                "label": "Other long-term liabilities",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 1511800000
            },
            {
                "label": "LIABILITIES AND EQUITY",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 11732400000
            },
            {
                "label": "Commitments and contingencies",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Preferred stock, par value $0.001 per share",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Common stock, par value $0.0005 per share",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 100000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 47800000
            },
            {
                "label": "Accumulated other comprehensive loss",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -248300000
            },
            {
                "label": "Retained earnings",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": 16944100000
            },
            {
                "label": "Treasury stock, at cost",
                "concept": "TreasuryStockValue",
                "unit": "usd",
                "value": 2977100000
            },
            {
                "label": "Equity:",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 13766600000
            },
            {
                "label": "Noncontrolling interests",
                "concept": "MinorityInterest",
                "unit": "usd",
                "value": -6800000
            },
            {
                "label": "Equity:",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 13759800000
            },
            {
                "label": "LIABILITIES AND EQUITY",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 25492200000
            }
        ],
        "cf": [
            {
                "label": "Net income",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 3529100000
            },
            {
                "label": "Depreciation and amortization",
                "concept": "DepreciationDepletionAndAmortization",
                "unit": "usd",
                "value": 686900000
            },
            {
                "label": "Acquired in-process research and development",
                "concept": "ResearchAndDevelopmentInProcess",
                "unit": "usd",
                "value": 112500000
            },
            {
                "label": "Share-based compensation",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 119000000
            },
            {
                "label": "Contingent consideration",
                "concept": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
                "unit": "usd",
                "value": 91600000
            },
            {
                "label": "Deferred income taxes",
                "concept": "DeferredIncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": -44800000
            },
            {
                "label": "Other",
                "concept": "OtherNoncashIncomeExpense",
                "unit": "usd",
                "value": 68200000
            },
            {
                "label": "Accounts receivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": 254000000
            },
            {
                "label": "Inventory",
                "concept": "IncreaseDecreaseInInventories",
                "unit": "usd",
                "value": 31900000
            },
            {
                "label": "Accrued expenses and other current liabilities",
                "concept": "IncreaseDecreaseInAccruedLiabilities",
                "unit": "usd",
                "value": 100700000
            },
            {
                "label": "Income tax assets and liabilities",
                "concept": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
                "unit": "usd",
                "value": 315600000
            },
            {
                "label": "Other changes in operating assets and liabilities, net",
                "concept": "IncreaseDecreaseInOtherOperatingCapitalNet",
                "unit": "usd",
                "value": 81000000
            },
            {
                "label": "Cash flows from operating activities:",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": 4292300000
            },
            {
                "label": "Proceeds from sales and maturities of marketable securities",
                "concept": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
                "unit": "usd",
                "value": 7994700000
            },
            {
                "label": "Purchases of marketable securities",
                "concept": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
                "unit": "usd",
                "value": 6093800000
            },
            {
                "label": "Contingent consideration paid related to Fumapharm AG acquisition",
                "concept": "PaymentsToAcquireOtherProductiveAssets",
                "unit": "usd",
                "value": 1200000000
            },
            {
                "label": "Purchases of property, plant and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 544700000
            },
            {
                "label": "Acquired in-process research and development",
                "concept": "PaymentsToAcquireInProcessResearchAndDevelopment",
                "unit": "usd",
                "value": 112500000
            },
            {
                "label": "Acquisitions of intangible assets",
                "concept": "PaymentsToAcquireIntangibleAssets",
                "unit": "usd",
                "value": 3000000
            },
            {
                "label": "Purchase of Ionis Pharmaceuticals, Inc. stock",
                "concept": "PaymentsToAcquireOtherInvestments",
                "unit": "usd",
                "value": 462900000
            },
            {
                "label": "Other",
                "concept": "PaymentsForProceedsFromOtherInvestingActivities",
                "unit": "usd",
                "value": -1200000
            },
            {
                "label": "Cash flows from investing activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -421000000
            },
            {
                "label": "Purchases of treasury stock",
                "concept": "PaymentsForRepurchaseOfCommonStock",
                "unit": "usd",
                "value": 3000000000
            },
            {
                "label": "Payments related to issuance of stock for share-based compensation arrangements, net",
                "concept": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
                "unit": "usd",
                "value": 6700000
            },
            {
                "label": "Repayment of borrowings",
                "concept": "RepaymentsOfNotesPayable",
                "unit": "usd",
                "value": 3200000
            },
            {
                "label": "Net distribution to noncontrolling interest",
                "concept": "PaymentsToMinorityShareholders",
                "unit": "usd",
                "value": 36900000
            },
            {
                "label": "Net cash contribution to Bioverativ Inc.",
                "concept": "PaymentsOfCapitalDistribution",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Other",
                "concept": "ProceedsFromPaymentsForOtherFinancingActivities",
                "unit": "usd",
                "value": 11800000
            },
            {
                "label": "Cash flows from financing activities:",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": -3035000000
            },
            {
                "label": "Net increase (decrease) in cash and cash equivalents",
                "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease",
                "unit": "usd",
                "value": 836300000
            },
            {
                "label": "Effect of exchange rate changes on cash and cash equivalents",
                "concept": "EffectOfExchangeRateOnCashAndCashEquivalents",
                "unit": "usd",
                "value": -23400000
            }
        ],
        "ic": [
            {
                "label": "Net income attributable to Biogen Inc.",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": 3483900000
            },
            {
                "label": "Unrealized gains (losses) on securities available for sale, net of tax",
                "concept": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
                "unit": "usd",
                "value": -1800000
            },
            {
                "label": "Unrealized gains (losses) on cash flow hedges, net of tax",
                "concept": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
                "unit": "usd",
                "value": 109000000
            },
            {
                "label": "Unrealized gains (losses) on pension benefit obligation, net of tax",
                "concept": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
                "unit": "usd",
                "value": -200000
            },
            {
                "label": "Currency translation adjustment, net of tax",
                "concept": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
                "unit": "usd",
                "value": -38800000
            },
            {
                "label": "Net current period other comprehensive income (loss)",
                "concept": "OtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": 68600000
            },
            {
                "label": "Comprehensive income attributable to Biogen Inc.",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": 3552500000
            },
            {
                "label": "Comprehensive income (loss) attributable to noncontrolling interests, net of tax",
                "concept": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -45200000
            },
            {
                "label": "Comprehensive income",
                "concept": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 3597700000
            },
            {
                "label": "Product revenues",
                "concept": "Revenues",
                "unit": "usd",
                "value": 9926600000
            },
            {
                "label": "Inventory charges",
                "concept": "CostOfGoodsAndServicesSold",
                "unit": "usd",
                "value": 1327800000
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
                "unit": "usd",
                "value": 1985600000
            },
            {
                "label": "Selling, general and administrative",
                "concept": "SellingGeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 1515200000
            },
            {
                "label": "Amortization of acquired intangible assets",
                "concept": "AmortizationOfIntangibleAssets",
                "unit": "usd",
                "value": 493200000
            },
            {
                "label": "Collaboration profit (loss) sharing",
                "concept": "biib:Collaborationprofitlosssharing",
                "unit": "usd",
                "value": 129200000
            },
            {
                "label": "Acquired in-process research and development",
                "concept": "ResearchAndDevelopmentInProcess",
                "unit": "usd",
                "value": 112500000
            },
            {
                "label": "Restructuring charges",
                "concept": "RestructuringCharges",
                "unit": "usd",
                "value": 9200000
            },
            {
                "label": "Contingent consideration",
                "concept": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
                "unit": "usd",
                "value": 91600000
            },
            {
                "label": "Cost and expenses:",
                "concept": "CostsAndExpenses",
                "unit": "usd",
                "value": 5481100000
            },
            {
                "label": "Income from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": 4445500000
            },
            {
                "label": "Other income (expense), net",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": 39600000
            },
            {
                "label": "Income before income tax expense and equity in loss of investee, net of tax",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": 4485100000
            },
            {
                "label": "Income tax expense (benefit)",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 956000000
            },
            {
                "label": "Equity in loss of investee, net of tax",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Net income",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": 3529100000
            },
            {
                "label": "Net income (loss) attributable to NCI, net of tax",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 45200000
            },
            {
                "label": "Basic earnings per share attributable to Biogen Inc.",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": 16.86
            },
            {
                "label": "Diluted earnings per share attributable to Biogen Inc.",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": 16.83
            },
            {
                "label": "Weighted average number of common shares outstanding",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 206600000
            },
            {
                "label": "Shares used in calculating diluted earnings per share",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 207000000
            }
        ]
    }
}